Dutch well being insurer VGZ, on Monday introduced that it has invested €6M in NLC Well being Ventures (NLC), which is devoted to supporting early-stage healthcare improvements.
This funding marks the primary time a well being insurer has invested in NLC.
With this transfer, VGZ and NLC enter right into a strategic partnership to develop and develop impactful, modern corporations in healthcare.
This capital injection will allow NLC to increase to quite a few startups annually.
Since 2015, NLC has been bringing impactful improvements to sufferers on a big scale, with over 100 startups, 4 funds, and actions in 16 nations, all geared toward enhancing the standard of healthcare.
One such instance is Nicolab.
Nicolab considerably improves time-sensitive stroke therapies by AI-supported info trade between medical doctors and hospitals.
With this innovation, sufferers have a greater probability of emergency therapy to take away dangerous clots and are 1.8 occasions extra prone to reside independently after a stroke.
This results in a greater high quality of life and vital price financial savings for hospitals and society.
NLC performed a key position in making Nicolab’s stroke care answer out there.
NLC Well being Ventures: Lively well being know-how investor
Primarily based out of Amsterdam, NLC Well being Ventures is probably the most lively well being know-how investor in Europe and the world’s largest healthtech enterprise builder.
NLC finds, builds, and scales transformative well being improvements to supply extra sufferers with high quality care.
NLC is ‘BCorp,’ its funds adjust to SFDR9 tips, and so they contribute to ESG 3, 9, and 17.
“VGZ sees main challenges in healthcare, for which NLC can discover appropriate improvements, from world wide and construct them into full-fledged corporations. The funding from and cooperation with VGZ will make it attainable to get these improvements to sufferers sooner,” mentioned Bert-Arjan Millenaar, CEO and founding father of NLC Well being Ventures.
VGZ: A driver of healthcare innovation
VGZ is devoted to contributing to the way forward for healthcare and goals to be a pacesetter in sustainable funding. The “Voorop in Zorg” fund is a part of Coöperatie VGZ.
The fund invests 60 million in modern corporations that target retaining healthcare accessible and inexpensive.
It primarily targets (pre)seed and early-stage corporations concerned in Medtech, Healthtech, Digital Well being Providers, and knowledge trade.
Along with offering early-stage capital, VGZ additionally utilises its healthcare data and experience to expedite the event of those corporations, with the shared ambition of enhancing healthcare.
Kees Hamster, CFO of VGZ says, “VGZ can leverage its data and experience to assist corporations which can be about to enter the market or are within the means of additional scaling up within the Netherlands, by providing entry to know-how on reimbursements, market dimension, present care pathways, contracting, and income fashions.”
